Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Phosphagenics enters agreement to develop TPM-delivered antipsoriasis drug

Feb. 8, 2011

Progenics and Salix Pharma enter into license agreement for Relistor

Feb. 8, 2011

Lilly and JDRF to study beta-cell regeneration to treat type 1 diabetes

Feb. 7, 2011

Tacere Therapeutics achieves milestone under collaboration with Pfizer

Feb. 7, 2011

Galapagos and Merck & Co. agree to end strategic alliances

Feb. 7, 2011

Pfizer and Takeda sign copromotion agreements for rheumatoid arthritis products

Feb. 4, 2011

Apeiron acquires rights to hu14.18-IL2 from Merck KGaA

Feb. 4, 2011

Theratechnologies and Ferrer enter into agreement for tesamorelin in Europe

Feb. 4, 2011

Marina Biotech and Debiopharm partner for RNAi-based bladder cancer therapy

Feb. 4, 2011

Faron and Maruishi to collaborate on Traumakine program in Japan

Feb. 1, 2011

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...